Generic Name | Specification | Therapeutic Category | Status |
Clopidogrel Bisulphate (Form-2) | IP/USP/EP | Cardiovascular | Commercial |
Etodolac | IP/USP/EP | NSAID | Commercial |
Sparfloxacin | In-house | Antibiotic | Commercial |
Molnupiravir | In-house | Anti- viral | Commercial |
Dabigatran Etexilate Mesylate | In-house | Anti-Coagulant | Pilot Scale |
Camostat mesylate | In-house | Anti-Coagulant | Pilot Scale |
Rivaroxaban | In-house | Anti-Coagulant | Lab Scale |
Mirabegron | In-house | Anticholinergics | Pilot Scale |
Note: All Transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third parties’ patent rights in a specific country lies exclusively with the buyer.